The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Kidney J
Main Authors: Herrington, William G, Preiss, David, Haynes, Richard, von Eynatten, Maximilian, Staplin, Natalie, Hauske, Sibylle J, George, Jyothis T, Green, Jennifer B, Landray, Martin J, Baigent, Colin, Wanner, Christoph
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Errata
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7467589/
https://ncbi.nlm.nih.gov/pubmed/32905262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfz009
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki